Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-17-002671
Accepted
2017-10-13 00:15:18
Documents
1
Effectiveness Date
2017-10-12
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 605
  Complete submission text file 9999999995-17-002671.txt   1814
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-220749 | Film No.: 171135446
SIC: 2834 Pharmaceutical Preparations